•  
  •  
  •  
  •  

2025-12-04 15:58:01

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Supra Trends Ltd Launches New Brand – 'The South Factory'
  • Rail Vikas Nigam Ltd receives LOA from Southern Railway
  • Veritas India Ltd to dispose certain assets of subsidiary Verasco FZE
  • Reliance Industries Ltd and Surrey announce their partnership in Oval Invincibles franchise in The Hundred
  • Sugs Lloyd Ltd secures ₹43.37 Crore Order from Punjab State Power Corporation Ltd

Keywords Selected:  IOC

Research

  • Biocon Limited - Generics & research grow; biosimilar stagnates - ICICI Securities
  • Q4FY22 Result Update – Biocon Ltd - ICICI Direct
  • Biocon - Q4FY22 First Cut - ICICI Direct
  • Q3FY22 Result Update - Biocon Ltd - ICICI Direct
  • Q2FY22 Result Update - Biocon Ltd - ICICI Direct

Stock Report

  • Biocon Biologics Secures Market Entry Date for Denosumab Biosimilars in Europe and Rest of the World
  • Biocon Biologics' Drug Substance Facility in Bengaluru Classified as Voluntary Action Indicated
  • Biocon Pharma Ltd receives approval from USFDA for its ANDA
  • Loyal Equipments Ltd receives order from Indian Oil Corporation Ltd
  • Krebs Biochemicals and Industries Ltd Q2 FY2026 loss at Rs. 6.14 crores
  • Indian Oil Corporation Ltd consolidated Q2 FY2025-26 net profit climbs to Rs. 7817.55 crores
  • Biocon Biologics Receives Health Canada Approval for Yesintek™ and Yesintek™ I.V., a Biosimilar to Stelara®
  • Gulshan Polyols Ltd allocated to supply 175652 Kiloliters of Ethanol in ESY 2025-26
  • Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine
  • Biocon Limited updates on GMP inspection by USFDA at its Cranbury, New Jersey facility
  • Refex Renewables & Infrastructure Ltd consortium awarded 100 TPD Municipal Solid Waste based Bio-CNG plant in Tiruchirappalli
  • Biocon Pharma Ltd in partnership with Carnegie Pharmaceuticals LLC receives USFDA tentative approval for Rifaximin Tablets
  • Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
  • The Shipping Corporation of India Ltd signs MoU with BPCL, HPCL and IOCL
  • Qualitek Labs Limited receives order from Indian Oil Corporation Ltd
  • Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
  • U.S. FDA Completes Inspection at Biocon Biologics' Facility at Biocon Campus, Bengaluru, India
  • Solapur Bioenergy Systems Ltd begins generation and dispatch of Compressed Biogas from IOCL Gorakhpur CBG Plant
  • Cohance Lifesciences announces USD 10 mn investment in cGMP Bioconjugation Suite at NJ Bio, Princeton, NJ, U.S. to Accelerate ADC Innovation
  • Biocon Foundation and IISc Commemorate World Head & Neck Cancer Day
  • TPI India Limited secures Rs. 13.77 Crore New Order
  • Infosys Collaborates with Melbourne Archdiocese Catholic Schools to drive Network-Wide Digital Transformation
  • Biocon Biologics Expands Diabetes Portfolio with FDA Approval of Kirsty™
  • Biocon Biologics receives MHRA UK Approval for Vevzuo® and Evfraxy®, Denosumab Biosimilars

Latest Post

  • Supra Trends Ltd Launches New Brand – 'The South Factory'
  • Rail Vikas Nigam Ltd receives LOA from Southern Railway
  • Veritas India Ltd to dispose certain assets of subsidiary Verasco FZE
  • Reliance Industries Ltd and Surrey announce their partnership in Oval Invincibles franchise in The Hundred
  • Sugs Lloyd Ltd secures ₹43.37 Crore Order from Punjab State Power Corporation Ltd


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024